GW
NVRO

Glenn Welling’s NEVRO CORP. NVRO Stock Holding History

Glenn Welling’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,442,956
Closed -$13.7M – 10
2024
Q3 		$13.7M Buy
2,442,956
+557,000
+30% +$3.9M 2.21% 9
2024
Q2 		$15.9M Hold
1,885,956
– – 2.72% 12
2024
Q1 		$27.2M Sell
1,885,956
-282,207
-13% -$4.67M 4.41% 10
2023
Q4 		$46.7M Buy
+2,168,163
New +$38.7M 6.83% 8

Other funds holding NVRO

ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Glenn Welling's NVRO Position: Q4 2024 in Review

Glenn Welling sold out of NEVRO CORP. (NVRO) in Q4 2024, closing a stake of 2,442,956 shares — an estimated $13.7M sold.

Glenn Welling first reported a position in NVRO in Q4 2023 and held it in 4 quarters. The position peaked at $46.7M in Q4 2023. 129 funds tracked by Wall St. Rank hold NVRO as of Q4 2024.

  • Glenn Welling reported no remaining NEVRO CORP. position as of Q4 2024 after selling out during the quarter.
  • Glenn Welling sold 2,442,956 NEVRO CORP. shares in Q4 2024, an estimated $13.7M.
  • Glenn Welling first reported a position in NEVRO CORP. in Q4 2023 and held it in 4 quarters.
  • Glenn Welling's NEVRO CORP. position peaked at $46.7M in Q4 2023.
  • 129 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2024.

Based on Engaged Capital's 13F filing for Q4 2024, filed 14 Feb 2025.